Abstract:AIM: To investigate the synergic effect of survivin antisense oligonucleotide (ASODN) combined with bcl-2 ASODN on apoptosis in lung cancer cell lines, and probe into its anti-cancer effect. METHODS ① The experiment was carried out in the immunological laboratory of Bengbu Medical College between August 2002 and April 2003. The NCI-H446 cells at logarithmic phase were divided into 6 groups: blank control group, liposomes 10 mg/L group (only blank liposomes was added), NSODN 500 nmol/L group (the first 3 groups were the control groups), survivin ASODN 500 nmol/L group, bcl-2 ASODN 5 μmol/L group, survivin ASODN 500 nmol/L +bcl-2 ASODN 5 μmol/L group (different oligonucleotides were transfected under mediation of liposomes, and then the cells were collected for the following tests). ② Under medium of liposomes, the lung cancer cell lines, NCI-H446 and SPC-A1 were transferred with survivin ASODN, and the survivin mRNA expression was detected with reverse transcription-polymerase chain reaction (RT-PCR) at 72 hours. Apoptosis index=(resting phase/DNA G1 phase)/whole cell cycle ×100%. Proliferation index=(DNA synthesis phase+G2 phase/M phase/whole cell cycle ×100%. ③ After NCI-H446 cell was treated with survivin ASODN alone or combined with bcl-2 ASODN, the cell growth inhibitory rate of NCI-H446 cell was detected with methyl-thiazol-tetrazolium (MTT) assay, and the interaction index of the two drugs was calculated, and the cell death rate was detected with trypan blue staining. ④ The analysis of variance and q test were applied in comaparing the difference of measurement data. RESULTS: ① The surviving gene expression was observed in both lung cancer cell lines. After cell line was treated with survivin ASODN, the growth inhibition and apoptosis occurred, and the survivin mRNA was obviously down-regulated, and the survivin mRNA inhibitory rates of NCI-H446 and SPC-A1 cells after treated with ASODN for 72 hours were 62.72% and 67.43% respectively. ② The results of MTT assay showed that both survivin ASODN and bcl-2 ASODN alone had the effect of growth suppression on NCI-H446 cells. The cell growth inhibitory rate of survivin ASODN combined with bcl-2 ASODN was 64.9%, was superior to that of alone application (bcl-2 ASODN alone was 34.2%) (P < 0.01), and the interaction index of the two drugs was 0.708. The trypan blue staining showed that the cell death rate in the survivin ASODN 500 nmol/L + bcl-2 ASODN 5 μmol/L group was 62.1%, which was higher than those of alone application (31.4% and 41.4%). The flow cytometer indicated that both survivin ASODN and bcl-2 ASODN could induce apoptosis as compared with the control groups, the apoptosis rates were 43.6% and 30.7% respectively, and it increased to 58.6% in the survivin ASODN 500 nmol/L + bcl-2 ASODN 5 μmol/L group (P < 0.01). CONCLUSION: ① Survivin ASODN can inhibit the lung cancer cell lines survivin gene expression, and induce apoptosis and growth suppression. ② Survivin ASODN combined with bcl-2 ASODN have a significant synergic anti-cancer role

Survivin of Antisense Oligodeoxynucleotides Reverse Apoptotic Resistance Induced by Cisplatin in Lung Cells

Antisense Oligodeoxynucleotides Targeting Survivin Gene Reverse Apoptotic Resistance Induced by Cisplatin in Human Lung Adenocarcinoma Cells

[Effect of Down-Regulation of Survivin Gene on Apoptosis and Cisplatin Resistance in Cisplatin Resistant Human Lung Adenocarcinoma A549/CDDP Cells].

[Experimental Study of Antisense Oligodeoxynucleotide Targeting Survivin Gene for Cisplatin Resistant Human Lung Adeno-Carcinoma Xenograft in Nude Mice].

Oligonucleotide sensitizes A375 cells to cisplatin

Antisense Oligonucleotide Targeting Survivin Induces Apoptosis of SMMC-7721 Cell and Enhances Its Sensitivity to Chemotherapeutic Agents in Vitro

Enhancement of Cisplatin Sensitivity in Lung Cancer Xenografts by Liposome-Mediated Delivery of the Plasmid Expressing Small Hairpin RNA Targeting Survivin.

Silencing survivin expression by siRNA in lung cancer cell enhanced apoptosis and reversed cispla tin resistance

Apoptosis of lung cancer cell lines induced by apoptosis inhibiting gene survivin antisense oligonucleotide combined with bcl-2 antisense oligonucleotide

The synergic effect of survivin antisense oligonucleotide on apoptosis in lung cancer cell lines

Antisense oligonucleotide targeting survivin induces apoptosis of renal clear-cell carcinoma cells and enhances their sensitivity to epirubicin in vitro]

[Effects of Cyclooxygenase-2 Antisense Vector on Proliferation and Sensitivity to Cisplatin of H1299 Cells].

Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer

Influence of SiRNA Targeting Survivin on Chemosensitivity of H460/cDDP Lung Cancer Cells

[Antisense Oligonucleotide Targeting Survivin Affects the Proliferation and Apoptosis of SMMC-7721 Cells].

Biological Effects of Survivin Antisense Olignucleotide on Human Hepatocarcinoma Cells

Survivin antisense oligodeoxynucleotide mediated by polyethyleneimine enhances sensitivity to chemotherapy in SMMC-7721,a human hepatocelluar carcinoma cell line

[Relationship Between Survivin Expression and Chemosensitivity of Human Lung Cancer Cells].

SOX2 Knockdown with Sirna Reverses Cisplatin Resistance in NSCLC by Regulating APE1 Signaling.

Effects of antisense oligodeoxynucleotide of ATP7B gene on sensitivity of ovarian cancer SKOV3ipl cells to cisplatin chemotherapy

Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells.